Amgen, Inc. (AMGN)
443.84
+4.51
(+1.03%)
USD |
NASDAQ |
Aug 24, 16:00
444.00
+0.16
(+0.04%)
After-Hours: 19:58
Amgen Market Cap : 239.94B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 237.50B |
| August 20, 2026 | 234.47B |
| August 19, 2026 | 239.14B |
| August 18, 2026 | 229.91B |
| August 17, 2026 | 226.72B |
| August 14, 2026 | 224.46B |
| August 13, 2026 | 225.88B |
| August 12, 2026 | 224.99B |
| August 11, 2026 | 223.97B |
| August 10, 2026 | 225.54B |
| August 07, 2026 | 222.16B |
| August 06, 2026 | 218.86B |
| August 05, 2026 | 220.47B |
| August 04, 2026 | 210.84B |
| August 03, 2026 | 204.82B |
| July 31, 2026 | 208.22B |
| July 30, 2026 | 209.56B |
| July 29, 2026 | 209.56B |
| July 28, 2026 | 212.51B |
| July 27, 2026 | 203.41B |
| July 24, 2026 | 203.29B |
| July 23, 2026 | 200.83B |
| July 22, 2026 | 197.89B |
| July 21, 2026 | 197.99B |
| July 20, 2026 | 196.87B |
| Date | Value |
|---|---|
| July 17, 2026 | 198.02B |
| July 16, 2026 | 200.88B |
| July 15, 2026 | 193.71B |
| July 14, 2026 | 192.05B |
| July 13, 2026 | 194.86B |
| July 10, 2026 | 196.45B |
| July 09, 2026 | 196.57B |
| July 08, 2026 | 198.94B |
| July 07, 2026 | 198.99B |
| July 06, 2026 | 198.10B |
| July 02, 2026 | 202.27B |
| July 01, 2026 | 195.33B |
| June 30, 2026 | 195.76B |
| June 29, 2026 | 194.59B |
| June 26, 2026 | 193.39B |
| June 25, 2026 | 190.42B |
| June 24, 2026 | 189.67B |
| June 23, 2026 | 187.28B |
| June 22, 2026 | 186.05B |
| June 18, 2026 | 182.20B |
| June 17, 2026 | 184.39B |
| June 16, 2026 | 187.73B |
| June 15, 2026 | 189.18B |
| June 12, 2026 | 191.70B |
| June 11, 2026 | 191.09B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 182.13B |
| Regeneron Pharmaceuticals, Inc. | 85.69B |
| AbbVie, Inc. | 467.37B |
| Biogen, Inc. | 32.21B |
| Vertex Pharmaceuticals, Inc. | 138.77B |
Market Cap Related Metrics
| PE Ratio | 27.57 |
| PS Ratio | 6.312 |
| PEG Ratio | 0.8696 |
| Price to Book Value | 20.53 |
| Price to Free Cash Flow | 23.70 |
| Price | 443.84 |
| Earnings Yield | 3.63% |
| PEGY Ratio | 0.8117 |
| Operating PE Ratio | 18.95 |
| Normalized PE Ratio | 25.16 |